Blood Glucose Monitoring Devices Market Size Worth USD 31.31 Billion By 2034 | CAGR: 8.1%

The blood glucose monitoring devices market size is expected to reach USD 31.31 billion by 2034, according to a new study by Polaris Market Research. The report “Blood Glucose Monitoring Devices Market Size, Share, Trends, Industry Analysis Report: By Product, End-Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) – Market Forecast, 2025–2034.” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blood glucose monitoring devices market encompasses technologies designed to measure and manage blood glucose levels, which are crucial for diabetic patients. The rising global prevalence of diabetes, driven by unhealthy lifestyles, aging populations, and genetic factors, has significantly increased the demand for effective glucose management solutions. As awareness of the importance of monitoring blood glucose levels continues to grow, both patients and healthcare providers are advancing these technologies to enhance diabetes care.

Technological advancements are playing a crucial role in the growth of the blood glucose monitoring devices market. Innovations such as non-invasive glucose monitoring, improved sensor accuracy, and enhanced connectivity features in modern devices are making blood glucose monitoring more efficient and user-friendly. These advancements contribute to better disease management and improved patient outcomes, driving increased demand.

For instance, in July 2023, Dexcom, Inc. launched the next-generation Dexcom G7 Continuous Glucose Monitoring System, certified by Health Canada. This system is designed for individuals with diabetes aged two years and older.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/blood-glucose-monitoring-device-market/request-for-sample

The increasing adoption of wearable devices and smart glucose monitors is driving growth in real-time tracking and seamless data integration. The shift toward home-based testing, coupled with rising healthcare spending in emerging markets, further supports this trend. Companies that prioritize user-friendly, accurate, and affordable solutions, along with strategic partnerships and global market expansion, are well-positioned to capitalize on this growing trend.

Blood Glucose Monitoring Devices Market Report Highlights

• By product outlook, the self-monitoring devices segment dominated the market in 2024, mainly due to increasing consumer awareness, the convenience of home testing, and the rising prevalence of diabetes.
• The hospitals & clinics segment is expected to register the fastest CAGR due to the growing number of diabetic patients, increasing hospital admissions, advancements in technology, and a rising emphasis on continuous glucose monitoring for better patient management.
• North America dominated the market in 2024 due to factors such as the high prevalence of diabetes and advanced healthcare infrastructure in countries like the United States and Canada.
• Asia Pacific is expected to register the fastest CAGR, owing to the rising prevalence of diabetes in countries such as China and India, where increasing urbanization and lifestyle changes contribute to higher diabetes rates.

• The key market players include Abbott Laboratories; Acon Laboratories Inc.; ARKRAY Inc.; Bayer AG; Becton, Dexcom, Inc.; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Johnson & Johnson; Novo Nordisk A/S; Sanofi; Terumo Corporation; Ypsomed.

Polaris Market Research has segmented the blood glucose monitoring devices market report based on product, end-use, and region:

By Product Outlook (Revenue – USD Billion, 2020-2034)

• Self-monitoring Devices
  • Blood Glucose Meter
  • Testing Strips
  • Lancets
• Continuous Blood Glucose Monitoring Devices
  • Sensors
  • Transmitter & Receiver
  • Insulin Pumps

By End-Use Outlook (Revenue–USD Billion, 2020-2034)

• Hospitals & Clinics
• Diagnostic Centers
• Home Care Settings

By Regional Outlook (Revenue–USD Billion, 2020-2034)

• North America

• US
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific

• Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of the Middle East & Africa

Blood Glucose Monitoring Device Report Scope